Learn More
Medchemexpress LLC Lapatinib-d4 (GW572016-d4; GW2016-d4) | 1184263-99-7 | 99.0% | C29H22D4ClFN4O4S | 5 MG

Supplier: Medchemexpress LLC HY50898S5MG
Lapatinib-d4 is the deuterium-labeled version of Lapatinib, a potent, orally active inhibitor of the ErbB-2 and EGFR tyrosine kinase domains. It is suitable for research use only. Deuteration, which involves incorporating stable heavy isotopes into drug molecules, serves as a tracer for quantitation during drug development and can influence the pharmacokinetic and metabolic profiles of drugs.
- Used as a tracer
- Used as an internal standard for quantitative analysis by NMR, GC-MS, or LC-MS
- Incorporates stable heavy isotopes to influence pharmacokinetic and metabolic profiles of drugs
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.